ETIZOLA 0.25MG TABLET 15'S

Yes, there are several reports mentioning the abuse potential of ETIZOLA 0.25MG TABLET 15'S. Therefore, it should be used with caution in patients prone to drug abuse.

As compared to other benzodiazepines, ETIZOLA 0.25MG TABLET 15'S has lesser sedative effects, lower dependence, and lower tolerance. However, long-term use can reduce the effectivity of the medicine and may cause dependence and addiction.

Stopping ETIZOLA 0.25MG TABLET 15'S suddenly may cause withdrawal symptoms which may include anxiety, insomnia, headache, dizziness, ringing sound in ear (tinnitus), eating disorder (anorexia), vomiting, nausea, tremor, weakness, excessive sweating (perspiration), irritability, hypersensitivity to visual and auditory stimuli. Stopping the medicine suddenly may also cause palpitations, fast heart rate and postural hypotension (drop in blood pressure on standing). In severe and rare cases of withdrawal from high doses, patients may develop seizures, mental disorder (psychosis), agitation, confusion, and hallucinations.

Oral doses of ETIZOLA 0.25MG TABLET 15'S begin working within 30-60 minutes and peak at 3-4 hours. The medicine remains in the body for 6-8 hours although higher doses can last longer.

Yes, like benzodiazepines, it causes muscle relaxation, but otherwise it is mainly used for anxiety.

Like other benzodiazepines, it causes sleepiness but is mainly used for anxiety disorder. It increases total sleep time and decreases the proportion of rapid eye movement (REM) sleep, wherein your eyes move quickly in different directions. ETIZOLA 0.25MG TABLET 15'S had no effect on sleep latency (amount of time it takes you to go from being fully awake to being asleep).

No, ETIZOLA 0.25MG TABLET 15'S is not an antidepressant. It is used for the treatment of generalized anxiety disorder with depressive symptoms. But, it may affect patient's mood.

Etizola 0.25 contains etizolam, a thienodiazepine with anxiolytic and sedative properties. It is generally prescribed for short‑term management of anxiety disorders, panic symptoms, and insomnia associated with anxiety. The exact indication for an individual patient is determined by the prescribing doctor after clinical assessment.

Etizola 0.25 enhances the effect of gamma‑aminobutyric acid (GABA), the main inhibitory neurotransmitter in the central nervous system. By binding to specific receptor sites associated with the GABA‑A receptor complex, etizolam increases GABAergic activity, which reduces neuronal excitability. This leads to reduced anxiety, sedation, muscle relaxation, and anticonvulsant effects.

Etizola 0.25 should be taken exactly as prescribed by your doctor, usually by mouth with water, with or without food. Do not change the dose, frequency, or duration on your own. If you miss a dose, take it when you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed one. Follow the schedule and instructions provided by your healthcare professional.

Etizolam, the active ingredient in Etizola 0.25, can cause tolerance, physical dependence, and withdrawal symptoms, particularly when used at higher doses or for prolonged periods. Misuse, such as taking more than prescribed or using it without medical supervision, increases the risk of dependence and problematic use. To minimize this risk, use the medicine only as directed and for the shortest duration necessary, and consult your doctor before stopping.

Common side effects include drowsiness, dizziness, fatigue, slowed reaction time, impaired concentration, and muscle weakness. Some people may experience headache, confusion, blurred vision, dry mouth, nausea, constipation, or changes in libido. These effects are usually dose‑related. If side effects are severe, persistent, or interfere with daily activities, contact your doctor for review.

No. Alcohol and Etizola 0.25 both depress the central nervous system. Taking them together can markedly increase drowsiness, impair coordination and judgment, and in severe cases depress breathing and heart function. You should avoid alcohol completely while taking Etizola 0.25 and discuss any regular alcohol intake with your doctor before starting therapy.

Etizola 0.25 can cause drowsiness, dizziness, blurred vision, and slowed reaction time, which can significantly impair your ability to drive or operate machinery safely. Until you know how the medicine affects you, avoid driving, using heavy machinery, or performing tasks that require full alertness. If you feel sedated or less alert than usual, do not drive and inform your doctor.

Use of Etizola 0.25 during pregnancy is generally not recommended unless the potential benefit clearly outweighs the potential risk, and only under specialist supervision. Exposure, especially in late pregnancy, may be associated with neonatal respiratory depression, low muscle tone, or withdrawal symptoms in the newborn. If you are pregnant, planning pregnancy, or become pregnant while taking Etizola 0.25, consult your doctor promptly to review treatment options.

Etizolam may pass into breast milk, and there is a potential risk of sedation, poor feeding, or respiratory depression in the breastfed infant. Therefore, Etizola 0.25 is generally avoided during breastfeeding unless your doctor decides that the benefit to the mother outweighs the risk to the infant and appropriate monitoring is possible. Discuss breastfeeding plans with your healthcare provider before starting or continuing this medicine.

Do not stop Etizola 0.25 suddenly, especially if you have been taking it regularly for more than a short period. Abrupt discontinuation can lead to withdrawal symptoms such as rebound anxiety, insomnia, restlessness, tremors, sweating, palpitations, and, rarely, seizures. Consult your doctor, who may recommend a gradual dose reduction schedule to minimize withdrawal effects and monitor your symptoms during the taper.

Etizola 0.25 is generally avoided in people with known hypersensitivity to etizolam or related compounds, severe respiratory insufficiency, acute intoxication with alcohol or other central nervous system depressants, and in some cases of severe liver impairment. Caution and specialist input are required in patients with a history of substance use disorder, depression, suicidal ideation, sleep apnoea, or significant kidney or liver disease. Your doctor will assess your overall health and medication profile before prescribing.